A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Herpes Zoster Vaccine
Clinical trial NCT06801509 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06801509
- Sponsor
- Sinocelltech Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-15
- Primary completion
- 2025-11-10
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.